© Reuters. Merck&Co earnings beat by $0.05, revenue topped estimates
Investing.com – Merck&Co (NYSE: MRK) reported first quarter EPS of $1.40, $0.05 better than the analyst estimate of $1.35. Revenue for the quarter came in at $14.49B versus the consensus estimate of $13.78B.
Guidance
Merck&Co sees FY 2023 EPS of $6.88-$7.00 versus the analyst consensus of $6.91.
Merck&Co sees FY 2023 revenue of $57.70B-$58.90B versus the analyst consensus of $58.30B.
Merck&Co’s stock price closed at $113.43. It is up 7.64% in the last 3 months and up 28.05% in the last 12 months.
Merck&Co saw 0 positive EPS revisions and 6 negative EPS revisions in the last 90 days. See Merck&Co’s stock price’s past reactions to earnings here.
According to InvestingPro, Merck&Co’s Financial Health score is “great performance”.
Check out Merck&Co’s , and Merck&Co’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Read the full article here
